Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
Or is the product potentially impure
Transitioning between concentrations If your pharmacy changes your vial concentration (common when moving from initiation vials to maintenance vials), recalculate your syringe units immediately
Gut-brain and neurological models : Some preclinical literature has examined BPC-157 in nervous-system models, investigating interactions along the gut-brain axis and reporting effects on certain neurotransmitter pathways, including dopaminergic and serotonergic systems in rodents
It could be contaminated with harmful substances or contain a different dose than whats advertised
Description Description Wolverine (BPC-157 + TB-500) 5mg + 5mg (Blend) combines BPC-157 and TB-500 (Thymosin Beta-4 fragment, TB4-400/43aa) in a single lyophilized vial
